COM(2004)737 EU - Regulation
Compulsory licensing of patents relating to the manufacture of pharmaceutical products for export to countries with public health problems - Main contents
Please note
This page contains a limited version of this dossier in the Parlementaire Monitor.
Contents
official title
Proposal for a Regulation of the European Parliament and of the Council on compulsory licensing of patents relating to the manufacture of pharmaceutical products for export to countries with public health problems| Legal instrument | Regulation |
|---|---|
| Decision making procedure | ordinary legislative procedure (COD) |
| reference by COM-number i | COM(2004)737  |
| Additional COM-numbers | SEC(2004)1348 |
| procedure number i | 2004/0258(COD) |
| CELEX number i | 52004PC0737 |
| Document | 29-10-2004 |
|---|---|
| Online publication | 29-10-2004 |
| Decision | 17-05-2006; Verordening 2006/816 |
| Publication in Official Journal i | 09-06-2006; Special edition in Romanian: Chapter 13 Volume 053,Special edition in Croatian: Chapter 13 Volume 063,Special edition in Bulgarian: Chapter 13 Volume 053,OJ L 157, 9.6.2006 |
This page is also available in a full version containing the latest state of affairs, the summary of the European Parliament Legislative Observatory, the legal basis, the legal context, other dossiers related to the dossier at hand, the stakeholders involved (e.g. European Commission directorates-general, European Parliament committees, Council configurations and even individual EU Commissioners and Members of the European Parliament) and finally documents of the European Parliament, the Council of Ministers and the European Commission.
The full version is available for registered users of the EU Monitor by ANP and PDC Informatie Architectuur.
The EU Monitor enables its users to keep track of the European process of lawmaking, focusing on the relevant dossiers. It automatically signals developments in your chosen topics of interest. Apologies to unregistered users, we can no longer add new users.This service will discontinue in the near future.